ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension

Sponsor
Massachusetts General Hospital
Status
Active, not recruiting
ClinicalTrials.gov ID
For more information, see ClinicalTrials.gov NCT05056896
This research study is studying a drug intervention as a possible chemoprevention strategy for colorectal cancer.

The name of the study intervention involved in this study is:

* Low Dose Aspirin
Intervention
Aspirin, Placebo
Condition
Colorectal Cancer
Investigators
Andrew T Chan, MD, MPH

See list of participating sites